Breaking News

CMIC Group Establishes CMIC BIO

Single-use facility in Shizuoka, Japan will provide process development and GMP manufacturing of antibody drugs using mammalian cell line.

By: Contract Pharma

Contract Pharma Staff

CMIC HOLDINGS Co., Ltd. has established CMIC BIO Co., Ltd., a fully-owned subsidiary that offers Contract Development and Manufacturing Organization (hereinafter CDMO) services for biopharmaceutical drug substance. CMIC Bio has a single-use facility in Shizuoka, Japan for process development and GMP manufacturing of antibody drug using mammalian cell line. The facility will be fully operational beginning October 2020. For the period from April 2014 to September 2019, CMIC JSR Biologics Co., L...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters